395 related articles for article (PubMed ID: 32641861)
1. CRISPR-based functional genomics for neurological disease.
Kampmann M
Nat Rev Neurol; 2020 Sep; 16(9):465-480. PubMed ID: 32641861
[TBL] [Abstract][Full Text] [Related]
2. Towards elucidating disease-relevant states of neurons and glia by CRISPR-based functional genomics.
Leng K; Kampmann M
Genome Med; 2022 Nov; 14(1):130. PubMed ID: 36401300
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 Genome Editing: A Promising Tool for Therapeutic Applications of Induced Pluripotent Stem Cells.
Zhang Y; Sastre D; Wang F
Curr Stem Cell Res Ther; 2018; 13(4):243-251. PubMed ID: 29446747
[TBL] [Abstract][Full Text] [Related]
4. A new era in functional genomics screens.
Przybyla L; Gilbert LA
Nat Rev Genet; 2022 Feb; 23(2):89-103. PubMed ID: 34545248
[TBL] [Abstract][Full Text] [Related]
5. High-throughput CRISPRi and CRISPRa technologies in 3D genome regulation for neuropsychiatric diseases.
Jones IR; Ren X; Shen Y
Hum Mol Genet; 2022 Oct; 31(R1):R47-R53. PubMed ID: 35972825
[TBL] [Abstract][Full Text] [Related]
6. CRISPRi and CRISPRa Screens in Mammalian Cells for Precision Biology and Medicine.
Kampmann M
ACS Chem Biol; 2018 Feb; 13(2):406-416. PubMed ID: 29035510
[TBL] [Abstract][Full Text] [Related]
7. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi.
Bendixen L; Jensen TI; Bak RO
Mol Ther; 2023 Jul; 31(7):1920-1937. PubMed ID: 36964659
[TBL] [Abstract][Full Text] [Related]
9. Decoding the noncoding genome via large-scale CRISPR screens.
Shukla A; Huangfu D
Curr Opin Genet Dev; 2018 Oct; 52():70-76. PubMed ID: 29913329
[TBL] [Abstract][Full Text] [Related]
10. iCSDB: an integrated database of CRISPR screens.
Choi A; Jang I; Han H; Kim MS; Choi J; Lee J; Cho SY; Jun Y; Lee C; Kim J; Lee B; Lee S
Nucleic Acids Res; 2021 Jan; 49(D1):D956-D961. PubMed ID: 33137185
[TBL] [Abstract][Full Text] [Related]
11. Gene Modulation with CRISPR-based Tools in Human iPSC-Cardiomyocytes.
Han JL; Entcheva E
Stem Cell Rev Rep; 2023 May; 19(4):886-905. PubMed ID: 36656467
[TBL] [Abstract][Full Text] [Related]
12. Current status of potential applications of repurposed Cas9 for structural and functional genomics of plants.
Seth K; Harish
Biochem Biophys Res Commun; 2016 Nov; 480(4):499-507. PubMed ID: 27955725
[TBL] [Abstract][Full Text] [Related]
13. Pooled CRISPR-Based Genetic Screens in Mammalian Cells.
Chan K; Tong AHY; Brown KR; Mero P; Moffat J
J Vis Exp; 2019 Sep; (151):. PubMed ID: 31545321
[TBL] [Abstract][Full Text] [Related]
14. Use of CRISPR/Cas ribonucleoproteins for high throughput gene editing of induced pluripotent stem cells.
Wang Q; Chear S; Wing K; Stellon D; Nguyen Tran MT; Talbot J; Pébay A; Hewitt AW; Cook AL
Methods; 2021 Oct; 194():18-29. PubMed ID: 33607266
[TBL] [Abstract][Full Text] [Related]
15. CRISPRi: a way to integrate iPSC-derived neuronal models.
Franks SNJ; Heon-Roberts R; Ryan BJ
Biochem Soc Trans; 2024 Apr; 52(2):539-551. PubMed ID: 38526223
[TBL] [Abstract][Full Text] [Related]
16. Functional genomics in stem cell models: considerations and applications.
Shevade K; Peddada S; Mader K; Przybyla L
Front Cell Dev Biol; 2023; 11():1236553. PubMed ID: 37554308
[TBL] [Abstract][Full Text] [Related]
17. Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies.
McTague A; Rossignoli G; Ferrini A; Barral S; Kurian MA
Front Genome Ed; 2021; 3():630600. PubMed ID: 34713254
[TBL] [Abstract][Full Text] [Related]
18. Application of CRISPR genetic screens to investigate neurological diseases.
So RWL; Chung SW; Lau HHC; Watts JJ; Gaudette E; Al-Azzawi ZAM; Bishay J; Lin LT; Joung J; Wang X; Schmitt-Ulms G
Mol Neurodegener; 2019 Nov; 14(1):41. PubMed ID: 31727120
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 Technology as a Modern Genetic Manipulation Tool for Recapitulating of Neurodegenerative Disorders in Large Animal Models.
Barazesh M; Mohammadi S; Bahrami Y; Mokarram P; Morowvat MH; Saidijam M; Karimipoor M; Kavousipour S; Vosoughi AR; Khanaki K
Curr Gene Ther; 2021; 21(2):130-148. PubMed ID: 33319680
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9 for cancer research and therapy.
Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
